[ sulge aken ]

Elulookirjeldus (CV)
1.Eesnimi Marika
2.Perekonnanimi Mikelsaar
3.Töökoht Tartu Ülikool, Mikrobioloogia instituut
4.Ametikoht erakorraline professor, meditsiiniline biotehnoloogia
5.Sünniaeg 12.11.1938 (päev.kuu.aasta)
6.Haridus kõrgem
Tartu ülikool, Arstiteaduskond 1963.
7.Teenistuskäik 1963-1965 stazöör TRÜ mikrobioloogia kateeder
1965-1968 aspirantuur TRÜ mikrobioloogia kateeder
1970-1979 nooremteadur, TRÜ meditsiini kesklaboratoorium
1979-1993 vanemteadur, TRÜ meditsiini kesklaboratoorium
1993-2003 professor, juhataja Tartu Ülikooli mikrobioloogia instituut
2003 - .... erakorraline professor, meditsiiniline biotehnoloogia
8.Teaduskraad meditsiinikandidaat
meditsiinidoktor
9.Teaduskraadi välja
andnud asutus, aasta
Tartu Riiklik Ülikool, 1969
Tartu Ülikool, 1993
10.Tunnustused 1994 EV teaduspreemia meditsiinis
2002 EV teaduspreemia meditsiinis
11.Teadusorganisatsiooniline
ja –administratiivne
tegevus
1993 - 2002 Instituudi juhataja
1993 - 2002 TÜ Arstiteaduskonna nõukogu liige
1995- 1999 TÜ Meditsiini kraadinõukogu sekretär
12.Juhendamisel kaitstud
väitekirjad

Epp Songisepp, DSc, 2005, juh. Marika Mikelsaar. Evaluation of technological and functional properties of the new probiotic Lactobacillus fermentum ME-3. Tartu ülikool

Krista Lõivukene, DSc, 2003, juh. Marika Mikelsaar, H-I. Maaroos. Helicobacter pylori in gastric microbial ecology and its antimicrobial susceptibility pattern.. Tartu Ülikool

Epp Songisepp, MSc, 2002, juh. Marika Mikelsaar, Priit Elias (EPMÜ). Eriliste biomarkeritega laktobatsillaarsed juuretised.. Tartu ülikool

Heidi Annuk, DSc, 2002, juh. Marika Mikelsaar, Elmar Arak. Selection of medicinal plants and intestinal lactobacilli as antimicrobial components for functional food.. Tartu ülikool

Helena Andreson, MSc, 2002, juh. Marika Mikelsaar. Helicobacter pylori Lõuna-Eestis levivate tüvede molekulaarsed virulentsusmarkerid. Tartu ülikool

Annika Krüüner, DSc, 2001, juh. Marika Mikelsaar, Sven Hoffner (Karolinska inst). Mycobacterium tuberculosis- spread and drug resistance in Estonia. Tartu Ülikool

Krista Lõivukene, MSc, 2000, juh. Marika Mikelsaar. Helicobacter pylori tüvede antibiootikumtundlikkus ja selle seos vacA ja cagA genotüübiga gastriidi ja peptilise haavandi korral. Tartu ülikool

Imbi Smidt, MSc, 1999, juh. Paul naaber, Marika Mikelsaar. Soole indigeensete laktobatsillide ja oportunistlike patogeenide C. difficile ja E. coli interaktsioon in vitro ja in vivo.. Tartu ülikool

Siiri Kõljalg, DSc, 1999, juh. Marika Mikelsaar. Acinetobacter - an important nosocomial pathogen. Tartu Ülikool

Epp Sepp, DSc, 1998, juh. Marika mikelsaar. Formation of intestinal microbial ecosystem in children. Tartu ülikool

Paul Naaber, DSc, 1997, juh. Marika Mikelsaar, Matti Maimets. Clostridium difficile infection and intestinal microbial ecology. Tartu Ülikool

Reet Mändar, DSc, 1996, juh. Marika Mikelsaar. Vaginal microflora during pregnancy and its transmission to newborn. Tartu Ülikool

Epp Sepp, MSc, 1994, juh. Marika Mikelsaar. Vastsündinu seedekulgla mikroobiökoloogia ja selle mõjustatavus probiootikumiga. Tartu Ülikool

13.Teadustöö põhisuunad Inimese mikrofloora osatähtsus mitmesugustel tervise seisunditel
Probiootikumid
Kliiniline mikrobioloogia - antibiootikumresistentsus, infektsioonide diagnostika
Mikkroobide virulentsusfaktorid
14.Jooksvad grandid Sihtfinantseering reg.nr. 0182555s03 (2003-2007)nimese mikroobiökoloogia ja selle mõjutamisvõimalused olulisemate eestis levinud krooniliste haiguste patogeneesis.
EU grant QLK1-2001-00135 (2001-2005)Funktsionaalsete seoste kindlakstegemine soole mikrofloora ja peremeesorganismi vahel.
EAS grant (2005-2007) OÜ tervisliku Piima Biotehnoloogiate Arenduskeskusega
EL NAS Tippkeskus (2003-2005(2006)
Eesti Tippkeskus (2003-2006)
Mikroobitüvede kollektsioonid Riiklik programm "Humanitaar ja loodusteaduslikud kogud" (2004-2008)
15.Teaduspublikatsioonid

Hütt, P., Shchepetova, J., Lõivukene, K., Mikelsaar, M.Determination of antagonistic activities of different probiotics against pathogens28.08 - 01.09.2005, 8th symposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands

Kasenõmm, P., Piirsoo, A., Kull, M., Kull, M. Jr, Mikelsaar, M. Selection of indicators for tonsillectomy in adults with recurrent tonsillitis. BMC Ear, Nose and Throat Disorders 2005, 5:7

Kullisaar, T., Lukman, A., Zilmer, K., Vihalemm, T., Mikelsaar, M., Zilmer, M.Probiotic L. fermentum ME-3 may have impact on the rehabilitation quality of elderly stroke patients18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Mikelsaar, M., Truusalu, K., Kullisaar, T., Naaber, P., Mikelsaar, R.-H., Zilmer, M.Effect of probiotic induced antioxidative response in experimental murine typhoid.XI International Congress of Bacteriology and Applied Microbiology, IUMS 2005, California, USA, July 2005

Sepp E., Julge K., Mikelsaar M., Björksten B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005;1141-1146.

Sepp E., Julge K., Mikelsaar M., Björkstten Intestinal microbiota and immunoglobulin E response in 5-year-old Estonian children. Clin.Exper. Allergy, 35, 1141-1146.

Songisepp, E., Kals, J., Hütt, P., Mändar, R., Mikelsaar, M.Impact of the probiotic L. fermentum ME-3 consumption with different formulations and daily doses on the fecal lactoflora, its composition and ME-3 fecal recoverySymposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands, August 28 to September 01, 2005

Songisepp E., Kals J., Kullisaar T., Hütt P., Mändar R., Zilmer M., Mikelsaar M. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutrition Journal, 2005, 4:22.

Zilmer, M., Songisepp, E., Kullisaar, T., Zilmer, K., Mikelsaar, M.Lactobacillus fermentum: probiotic and health characteristics essential for conception of functional food.18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Vihalemm, T., Kullisaar, T., Songisepp, E., Kaur, S., Zilmer, M.Probiotic fermented goats' milk influences glutathione metabolism in blood and skin of atopic dermatitis patients.18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Kasenõmm, P., Mesila, I., Piirsoo, A., Kull, M., Mikelsaar, M., Mikelsaar, R.-H. Macroscopic oropharyngeal signs indicating impaired defensive function of palatine tonsils in adults suffering from recurrent tonsillitis. APMIS, 2004, 112, 248-256.

Kõll-Klais, P., Mändar, R., Leibur, E., Kjaeldgaard M. High levels of salivary lactobacilli in Estonian schoolchildren. Eur. J. Paed. Dent., 2004, 2, 107-109.

Kõll-Klais, P., Mändar, R., Mikelsaar, M., Leibur, E. Subgingival microbial relations in chronic periodontitis and periodontal health. SOMED, Helsingör, Taani, 6.-9. Mai 2004

Maaroos, H.-I., Andreson, H., Lõivukene, K., Hütt, P., Kolk, H., Kull, I., Labotkin, K., Mikelsaar, M. The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting. BMC Gastroenterology, 2004, ,4, 27.

Mikelsaar, M., Mändar, R., Sepp, E., Annuk, H. Human lactic acid microflora and its role in the welfare of the host. In: Lactic Acid Bacteria. Eds. S. Salminen, A. von Wright, A. Ouwehand. Marcel Dekker Inc., 2004, 453-506.

Mikelsaar, R., Truusalu, K., Murde, M., Naaber, P., Mikelsaar, M. Probiotic lactobacilli enhance eradication of Salmonella Typhimurium in animal model. In: Abstr. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2004, Washington D.C., p. 61.

M. Mikelsaar. Probiotic lactobacilli vs. Helicobacter pylori. SOMED, Helsingör, Taani, 6.-9. Mai 2004

Naaber, P., Mikelsaar, M. Interactions between lactobacilli and antibiotic-associated diarrhea. In: Advances in Applied Microbiology. Eds. A.I. Laskin, J.W. Bennett, G.M. Gadd. Volume 54. Elsevier Inc., 2004, 231-260.

Naaber, P., Smidt, I., Štšepetova, J., Brilene, T., Annuk, H., Mikelsaar, M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol., 2004, 53, 551-554.

R.-M. Mikelsaar, K. Truusalu, M. Murde, P. Naaber, M. Mikelsaar Probiotic lactobacilli enhance eradication on S. Typhimurium in animal model. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, USA, 01.-03.11.2004

Songisepp, E., Kullisaar, T., Hütt, P., Elias, P., Brilene, T., Zilmer, M., Mikelsaar, M. A new probiotic cheese with antioxidative and antimicrobial activity. J. Dairy Sci., 2004, 87, 2017-2023.

Truusalu, K. The influence of antibacterial and antioxidative probiotic lactobacilli on gut mucosa in a mouse model of Salmonella infection. Microbial Ecology in Health and Disease 2004, 16:4, 180-187.

Andreson H., Maaroos H.-I., Mikelsaar M. Reliability of noninvasive Helicobacter pylori antigen stool test ImmunoCard STAT! HpSA in peptic ulcer patients after eradicative treatment. In: Helicobacter. Ed. D.G. Graham, Blackwell Publishing, 2003, 8, 4, p. 490.

Annuk, H., Shchepetova, J., Kullisaar, T., Songisepp, E., Zilmer, M., Mikelsaar, M. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol., 2003, 94, 403-412.

International Patent application: no. PCT/EE02/00006 28.06.2002. The strain of microorganism Lactobacillus fermentum ME-3 as novel antimicrobial and antioxidant probiotic. M. Mikelsaar, M. Zilmer, T. Kullisaar, H. Annuk, E. Songisepp. Avaldatud 09.01.03. numbri WO 030022131 all (http://ep.espacenet.com).

Kermes K., Punab M., Lõivukene K., Mändar R.. Anaerobic seminal fluid microflora in chronic prostatitis/chronic pelvic pain syndrome patients. Anaerobe 2003, 9, 117-123.

Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T., Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr., 2003, 90, 449-456.

Lõivukene K., Maaroos H., Mikelsaar M. Antimicrobial potential of lactobacilli against reference and wild Helicobacter pylori strains. Clin. Microbiol. Infect., 2003, S1, 143.

Lõivukene, K., Naaber, P. Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe, 2003, 9, 57-61.

Punab M., Lõivukene K., Kermes K., Mändar R. (2003). The limit of leukocytospermia from the microbiological viewpoint. Andrologia, 2003, 35, 271-278.

Sepp E, Kõljalg S, Truusalu K, Štšepetova L, Metsvaht T, Sau L, Jürna M, Mägi H, Allik M, Mikelsaaar M.Staphylococcus epidermidis ja Klebsiella pneumoniae-võimalikud hospitaalinfektsioonide tekitajad Eesti lasteintensiivarvi osakondades. Eesti Arst 2003, 82 (4) 239-248

Tapfer, H., Liigant, A., Simovart, H.E., Põldoja, E., Kokk, K., Naaber, P., Talvik, R. Dissemination of bacteria in multiple organs associated with apoptosis and macrophage activity in different stages of experimental sepsis. Scand. J. Surg., 2003, 92, 163-170.

viimati muudetud: 06.10.2005

Curriculum Vitae (CV)
1.First Name Marika
2.Surname Mikelsaar
3.Institution University of Tartu, Department of microbiology
4.Position c.o. professor, medical biotechnology
5.Date of birth 12.11.1938 (day.month.year)
6.Education Higher education, University of Tartu, medical faculty 1963
7.Research and
professional experience
1963-1965 residency by University of Tartu, dept. microbiology
1965-1968 Ph D studies by University of Tartu, dept. microbiology
1970-1979 jun. research associate by Central medical laboratory, University of Tartu
1979-1993 sen. research associate by Central medical laboratory, University of Tartu
1993-2003 professor, head of the department of microbiology
2003 - ... erakorraline professor, medical biotechnology
8.Academic degree cand. med.
doctor of medical sciences
9.Dates and sites of
earning the degrees
University of Tartu, 1969
University of Tartu, 1993
10.Honours/awards 1994 National Award in medical sciences
2002 National Award in medical sciences
11.Research-administrative
experience
1993-2003 Head of department of microbiology
1993-2002 member of the medical council of Tartu university
1995-1999 secretary of the medical council of tartu university
12.Supervised dissertations

Epp Songisepp, DSc, 2005, superv. Marika Mikelsaar. Evaluation of technological and functional properties of the new probiotic Lactobacillus fermentum ME-3. Tartu ülikool

Krista Lõivukene, DSc, 2003, superv. Marika Mikelsaar, H-I. Maaroos. Helicobacter pylori in gastric microbial ecology and its antimicrobial susceptibility pattern.. Tartu Ülikool

Epp Songisepp, MSc, 2002, superv. Marika Mikelsaar, Priit Elias (EPMÜ). Eriliste biomarkeritega laktobatsillaarsed juuretised.. Tartu ülikool

Heidi Annuk, DSc, 2002, superv. Marika Mikelsaar, Elmar Arak. Selection of medicinal plants and intestinal lactobacilli as antimicrobial components for functional food.. Tartu ülikool

Helena Andreson, MSc, 2002, superv. Marika Mikelsaar. Helicobacter pylori Lõuna-Eestis levivate tüvede molekulaarsed virulentsusmarkerid. Tartu ülikool

Annika Krüüner, DSc, 2001, superv. Marika Mikelsaar, Sven Hoffner (Karolinska inst). Mycobacterium tuberculosis- spread and drug resistance in Estonia. Tartu Ülikool

Krista Lõivukene, MSc, 2000, superv. Marika Mikelsaar. Helicobacter pylori tüvede antibiootikumtundlikkus ja selle seos vacA ja cagA genotüübiga gastriidi ja peptilise haavandi korral. Tartu ülikool

Imbi Smidt, MSc, 1999, superv. Paul naaber, Marika Mikelsaar. Soole indigeensete laktobatsillide ja oportunistlike patogeenide C. difficile ja E. coli interaktsioon in vitro ja in vivo.. Tartu ülikool

Siiri Kõljalg, DSc, 1999, superv. Marika Mikelsaar. Acinetobacter - an important nosocomial pathogen. Tartu Ülikool

Epp Sepp, DSc, 1998, superv. Marika mikelsaar. Formation of intestinal microbial ecosystem in children. Tartu ülikool

Paul Naaber, DSc, 1997, superv. Marika Mikelsaar, Matti Maimets. Clostridium difficile infection and intestinal microbial ecology. Tartu Ülikool

Reet Mändar, DSc, 1996, superv. Marika Mikelsaar. Vaginal microflora during pregnancy and its transmission to newborn. Tartu Ülikool

Epp Sepp, MSc, 1994, superv. Marika Mikelsaar. Vastsündinu seedekulgla mikroobiökoloogia ja selle mõjustatavus probiootikumiga. Tartu Ülikool

13.Current research program Role of human microflora in health and disease
Probiotics
Clinical microbiology - diagnostics, antibiotic resistance
Microbial virulence factors
14.Current grant funding Estonian Ministry of Education : Basic foundation reg.nr. 0182555s03 (2003-2007) Human microbial ecology and the possibilities for its modulation in the pathogenesis of main chronic diseases spread in Estonia
EU grant QLK1-2001-00135 (2001-2005) Functional assessment of interactions between the human gut microbiota and the host.
EAS grant (2005-2007)with R&D centre of Biotechnology of Healthy milk
EU NAS Centre of Excellence 2003-2005(2006)
EU Marie Curie Host Center (2005-2009)
Collections of microbial strains National program "Humanitarian and natural collections" 2004-2008
15.List of most important publications

Hütt, P., Shchepetova, J., Lõivukene, K., Mikelsaar, M.Determination of antagonistic activities of different probiotics against pathogens28.08 - 01.09.2005, 8th symposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands

Kasenõmm, P., Piirsoo, A., Kull, M., Kull, M. Jr, Mikelsaar, M. Selection of indicators for tonsillectomy in adults with recurrent tonsillitis. BMC Ear, Nose and Throat Disorders 2005, 5:7

Kullisaar, T., Lukman, A., Zilmer, K., Vihalemm, T., Mikelsaar, M., Zilmer, M.Probiotic L. fermentum ME-3 may have impact on the rehabilitation quality of elderly stroke patients18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Mikelsaar, M., Truusalu, K., Kullisaar, T., Naaber, P., Mikelsaar, R.-H., Zilmer, M.Effect of probiotic induced antioxidative response in experimental murine typhoid.XI International Congress of Bacteriology and Applied Microbiology, IUMS 2005, California, USA, July 2005

Sepp E., Julge K., Mikelsaar M., Björksten B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005;1141-1146.

Sepp E., Julge K., Mikelsaar M., Björkstten Intestinal microbiota and immunoglobulin E response in 5-year-old Estonian children. Clin.Exper. Allergy, 35, 1141-1146.

Songisepp, E., Kals, J., Hütt, P., Mändar, R., Mikelsaar, M.Impact of the probiotic L. fermentum ME-3 consumption with different formulations and daily doses on the fecal lactoflora, its composition and ME-3 fecal recoverySymposium on Lactic Acid Bacteria, Egmond aan Zee, The Netherlands, August 28 to September 01, 2005

Songisepp E., Kals J., Kullisaar T., Hütt P., Mändar R., Zilmer M., Mikelsaar M. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutrition Journal, 2005, 4:22.

Zilmer, M., Songisepp, E., Kullisaar, T., Zilmer, K., Mikelsaar, M.Lactobacillus fermentum: probiotic and health characteristics essential for conception of functional food.18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Vihalemm, T., Kullisaar, T., Songisepp, E., Kaur, S., Zilmer, M.Probiotic fermented goats' milk influences glutathione metabolism in blood and skin of atopic dermatitis patients.18th International Congress of Nutrition, September 19-23, 2005, Durban, South Africa

Kasenõmm, P., Mesila, I., Piirsoo, A., Kull, M., Mikelsaar, M., Mikelsaar, R.-H. Macroscopic oropharyngeal signs indicating impaired defensive function of palatine tonsils in adults suffering from recurrent tonsillitis. APMIS, 2004, 112, 248-256.

Kõll-Klais, P., Mändar, R., Leibur, E., Kjaeldgaard M. High levels of salivary lactobacilli in Estonian schoolchildren. Eur. J. Paed. Dent., 2004, 2, 107-109.

Kõll-Klais, P., Mändar, R., Mikelsaar, M., Leibur, E. Subgingival microbial relations in chronic periodontitis and periodontal health. SOMED, Helsingör, Taani, 6.-9. Mai 2004

Maaroos, H.-I., Andreson, H., Lõivukene, K., Hütt, P., Kolk, H., Kull, I., Labotkin, K., Mikelsaar, M. The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting. BMC Gastroenterology, 2004, ,4, 27.

Mikelsaar, M., Mändar, R., Sepp, E., Annuk, H. Human lactic acid microflora and its role in the welfare of the host. In: Lactic Acid Bacteria. Eds. S. Salminen, A. von Wright, A. Ouwehand. Marcel Dekker Inc., 2004, 453-506.

Mikelsaar, R., Truusalu, K., Murde, M., Naaber, P., Mikelsaar, M. Probiotic lactobacilli enhance eradication of Salmonella Typhimurium in animal model. In: Abstr. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2004, Washington D.C., p. 61.

M. Mikelsaar. Probiotic lactobacilli vs. Helicobacter pylori. SOMED, Helsingör, Taani, 6.-9. Mai 2004

Naaber, P., Mikelsaar, M. Interactions between lactobacilli and antibiotic-associated diarrhea. In: Advances in Applied Microbiology. Eds. A.I. Laskin, J.W. Bennett, G.M. Gadd. Volume 54. Elsevier Inc., 2004, 231-260.

Naaber, P., Smidt, I., Štšepetova, J., Brilene, T., Annuk, H., Mikelsaar, M. Inhibition of Clostridium difficile strains by intestinal Lactobacillus species. J. Med. Microbiol., 2004, 53, 551-554.

R.-M. Mikelsaar, K. Truusalu, M. Murde, P. Naaber, M. Mikelsaar Probiotic lactobacilli enhance eradication on S. Typhimurium in animal model. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, USA, 01.-03.11.2004

Songisepp, E., Kullisaar, T., Hütt, P., Elias, P., Brilene, T., Zilmer, M., Mikelsaar, M. A new probiotic cheese with antioxidative and antimicrobial activity. J. Dairy Sci., 2004, 87, 2017-2023.

Truusalu, K. The influence of antibacterial and antioxidative probiotic lactobacilli on gut mucosa in a mouse model of Salmonella infection. Microbial Ecology in Health and Disease 2004, 16:4, 180-187.

Andreson H., Maaroos H.-I., Mikelsaar M. Reliability of noninvasive Helicobacter pylori antigen stool test ImmunoCard STAT! HpSA in peptic ulcer patients after eradicative treatment. In: Helicobacter. Ed. D.G. Graham, Blackwell Publishing, 2003, 8, 4, p. 490.

Annuk, H., Shchepetova, J., Kullisaar, T., Songisepp, E., Zilmer, M., Mikelsaar, M. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol., 2003, 94, 403-412.

International Patent application: no. PCT/EE02/00006 28.06.2002. The strain of microorganism Lactobacillus fermentum ME-3 as novel antimicrobial and antioxidant probiotic. M. Mikelsaar, M. Zilmer, T. Kullisaar, H. Annuk, E. Songisepp. Avaldatud 09.01.03. numbri WO 030022131 all (http://ep.espacenet.com).

Kermes K., Punab M., Lõivukene K., Mändar R.. Anaerobic seminal fluid microflora in chronic prostatitis/chronic pelvic pain syndrome patients. Anaerobe 2003, 9, 117-123.

Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T., Zilmer, M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr., 2003, 90, 449-456.

Lõivukene K., Maaroos H., Mikelsaar M. Antimicrobial potential of lactobacilli against reference and wild Helicobacter pylori strains. Clin. Microbiol. Infect., 2003, S1, 143.

Lõivukene, K., Naaber, P. Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe, 2003, 9, 57-61.

Punab M., Lõivukene K., Kermes K., Mändar R. (2003). The limit of leukocytospermia from the microbiological viewpoint. Andrologia, 2003, 35, 271-278.

Sepp E, Kõljalg S, Truusalu K, Štšepetova L, Metsvaht T, Sau L, Jürna M, Mägi H, Allik M, Mikelsaaar M.Staphylococcus epidermidis ja Klebsiella pneumoniae-võimalikud hospitaalinfektsioonide tekitajad Eesti lasteintensiivarvi osakondades. Eesti Arst 2003, 82 (4) 239-248

Tapfer, H., Liigant, A., Simovart, H.E., Põldoja, E., Kokk, K., Naaber, P., Talvik, R. Dissemination of bacteria in multiple organs associated with apoptosis and macrophage activity in different stages of experimental sepsis. Scand. J. Surg., 2003, 92, 163-170.

last updated: 06.10.2005

[ sulge aken ]